Eizen Joshua M 4
4 · AN2 Therapeutics, Inc. · Filed Feb 28, 2025
Insider Transaction Report
Form 4
Eizen Joshua M
See Remarks
Transactions
- Award
Common Stock
2025-02-26+58,500→ 175,172 total - Award
Stock Option (right to buy)
2025-02-26+117,000→ 117,000 totalExercise: $1.13Exp: 2035-02-25→ Common Stock (117,000 underlying)
Footnotes (3)
- [F1]Represents restricted stock units ("RSUs") which vest as follows: 1/4th of the shares vests annually over four years from January 1, 2025, subject to the Reporting Person's continuous service as of such date.
- [F2]Includes (a) 31,500 RSUs which vest as follows: 1/4th of the RSUs vest annually over four years from November 4, 2024 (b) 22,500 RSUs which vest as follows: 1/3rd of the RSUs vest annually over three years from January 1, 2025 and (c) 45,000 RSUs which vest as follows: 2/3rd of the RSU vest on January 1, 2026 and 1/3rd of the RSUs vest on July 1, 2026, subject to the Reporting Person's continuous service as of such date.
- [F3]The shares subject to the option vest as follows: 1/48th of the shares vests monthly over four years from January 1, 2025, subject to the Reporting Person's continuous service as of such date.